FibroGen Inc (NASDAQ:FGEN)
| 10.58 Delayed Data As of Jun 30 |  -0.37 / -3.39%Today’s Change | 7.81 Today|||52-Week Range 27.55 | -24.96% Year-to-Date |
Latest FGEN News | Press Releases
No recent news for FibroGen Inc.
Today’s Trading
| Previous close | 10.93 |
| Today’s open | 10.81 |
| Day’s range | 10.46 - 11.18 |
| Volume | 864,536 |
| Average volume (3 months) | 919,217 |
| Market cap | $1.1B |
Data as of 4:01pm ET, 06/30/2022
Growth & Valuation
| Earnings growth (last year) | -49.08% |
| Earnings growth (this year) | -5.19% |
| Earnings growth (next 5 years) | -70.91% |
| Revenue growth (last year) | +33.46% |
| P/E ratio | NM |
| Price/Sales | 5.53 |
| Price/Book | 5.15 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADPTAdaptive Biotechnolo... | -0.13 | -1.58% |
| AVXLAnavex Life Sciences... | +0.12 | +1.21% |
| AMRNAmarin Corporation P... | -0.33 | -18.13% |
| --Oxford BioMedica PLC | -0.05 | -0.93% |
Data as of 4:02pm ET, 06/30/2022
Financials
| Next reporting date | August 8, 2022 |
| EPS forecast (this quarter) | -$0.92 |
| Annual revenue (last year) | $235.3M |
| Annual profit (last year) | -$290.0M |
| Net profit margin | -123.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
